Learning Objectives:
- Determine the impact of subtypes, biomarkers, risk assessment, and patient-related factors on therapeutic selection for patients with DLBCL across therapeutic lines
- Evaluate the efficacy/safety profiles of targeted and cellular therapies that have been evaluated for DLBCL treatment along the care continuum
- Implement proactive strategies to identify and mitigate the impact of adverse events associated with therapies used in the treatment of patients with DLBCL
- Apply nursing care strategies that focus on patient education and counselling in the context of managing treatment-related toxicities
Learning Objectives:
- Determine the pathological mechanism as well as diagnostic criteria and risk stratification methods in MPN
- Assess current as well as emerging strategies including emerging combinations for the treatment of patients with MPN
- Devise effective strategies for monitoring and management of treatment-associated adverse events and disease-associated complications in patients with MPN
- Employ nursing strategies to manage care plans for patients with MPN in the context of counselling on treatment-related toxicities and supportive care interventions
Learning Objectives:
- Detect ITP and monitor the condition after treatment initiation
- Determine efficacy and safety of evolving therapeutic approaches in the first-line setting and beyond
- Monitor and mitigate treatment-related adverse events
- Optimize outcomes by coordinating care and counseling patients and/or caregivers